The Hong Kong-based fixed income specialist has twelve months to launch an onshore China fund.

The Hong Kong-based fixed income specialist has twelve months to launch an onshore China fund.
Disease treatment is changing rapidly, leading to new therapies and better long-term results for patients — and creating investment opportunities, according to Andy Acker, portfolio manager, Janus Henderson Global Life Sciences and Dan Lyons, research analyst.
Cheap relative valuations, technical factors and regional policy actions support Asian corporate bonds, according to experts.
The firm favours attractively valued markets, such as emerging markets and China — and the UK.
The fund, run in partnership with American Century Investments, will be guided by UN sustainable development goals.
Asia is expected to be the world’s second largest wealth hub by 2024, according to Knight Frank.
RHB AM expects that it will be able to attract RM 100m ($23.7m) for its US-focused income fund in the next couple of months.
Nine funds were added on the list, six of which are managed by Pictet Asset Management.
After the coronavirus spread is under control, the firm believes China’s focus will turn to increasing investment in sanitation and waste treatment.
The collapse of global stock prices has delivered a sharp jolt to fund categories that had been buoyed by optimism at the start of the year.
Part of the Mark Allen Group.